Publications by authors named "Simon Helfgott"

Claim this Profile
R
Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and "decentralized" clinical recruitment design.
Gregory C McDermott, Mary Jeffway, Thany Seyok, Harrison Zhang, Elena Myasoedova, Simon Helfgott

Contemp Clin Trials· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line Tumor Necrosis Factor Inhibitor Therapy in the United States.
Colin Edgerton, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Jasvinder A Singh

ACR Open Rheumatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalized pustular psoriasis-like widespread eruption following COVID-19 infection in a patient with spondyloarthropathy on adalimumab.
Kanika Kamal, Grant J Riew, Baraa Hijaz, Simon M Helfgott, Alvaro C Laga

Exp Dermatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative.
Babette S Edgar, Adam S Cheifetz, Simon M Helfgott, Gideon P Smith, Tina Bandekar

J Manag Care Spec Pharm· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID-19 Pandemic.
Fotios Koumpouras, Simon Helfgott

Arthritis Rheumatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and predictors for sustained remission in rheumatoid arthritis.
Yoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, Michelle L Frits, Soo-Kyung Cho, Simon M Helfgott

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.
Yoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, Michelle L Frits, Soo-Kyung Cho, Simon M Helfgott

PLoS One· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed-effects association of single cells identifies an expanded effector CD4 T cell subset in rheumatoid arthritis.
Chamith Y Fonseka, Deepak A Rao, Nikola C Teslovich, Ilya Korsunsky, Susan K Hannes, Simon M Helfgott

Sci Transl Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial.
Jeffrey A Sparks, Maura D Iversen, Zhi Yu, Nellie A Triedman, Maria G Prado, Simon M Helfgott

Arthritis Care Res (Hoboken)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of pulmonary features and treatment approaches in the COPA syndrome.
Jessica L Tsui, Oscar A Estrada, Zimu Deng, Kristin M Wang, Christopher S Law, Simon M Helfgott

ERJ Open Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcium Pyrophosphate Crystal Inflammatory Arthritis (Pseudogout) with Myelodysplastic Syndrome: A New Paraneoplastic Syndrome?
Sara K Tedeschi, Richard M Stone, Simon M Helfgott

J Rheumatol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.
Deepak A Rao, Michael F Gurish, Jennifer L Marshall, Kamil Slowikowski, Chamith Y Fonseka, Simon M Helfgott

Nature· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic complications of systemic lupus erythematosus, sjögren syndrome, and rheumatoid arthritis.
Shamik Bhattacharyya, Simon M Helfgott

Semin Neurol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha.
Eben I Lichtman, Simon M Helfgott, Martin A Kriegel

Clin Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The research-based rheumatologist: strategies to remove the species from the endangered list.
Simon Helfgott

Arthritis Rheum· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study.
Yvonne C Lee, Lori B Chibnik, Bing Lu, Ajay D Wasan, Robert R Edwards, Simon M Helfgott

Arthritis Res Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
Samuel M Behar, Daniel S Shin, Agnes Maier, Jonathan Coblyn, Simon Helfgott

J Rheumatol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical problem-solving. A joint venture.
Abraham B Schwarzberg, Cristina B Alexander, Daniel J DeAngelo, Simon M Helfgott

N Engl J Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum sickness following treatment with rituximab.
Derrick J Todd, Simon M Helfgott

J Rheumatol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
Alyssa K Johnsen, Michael H Schiff, Philip J Mease, Larry W Moreland, Agnes L Maier, Simon M Helfgott

J Rheumatol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis?
Herbert T S Ang, Simon Helfgott

J Rheumatol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2002. A 21-year-old man with arthritis during treatment for hyperthyroidism.
Simon M Helfgott, R Neal Smith

N Engl J Med· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis